Cargando…

Use of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision‐Making Between Patients With Cancer and Clinicians

Detalles Bibliográficos
Autores principales:	Singh, Namrata, Grivas, Petros, Makris, Una E., Suarez‐Almazor, Maria E., O'Hare, Ann M., Barton, Jennifer L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267802/ https://www.ncbi.nlm.nih.gov/pubmed/37166652 http://dx.doi.org/10.1002/acr2.11552

Ejemplares similares

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)
por: Uhrenholt, Line, et al.
Publicado: (2019)

Adaptation of a Shared Decision-Making Tool for Early Rheumatoid Arthritis Treatment Decisions with Indigenous Patients
por: Umaefulam, Valerie, et al.
Publicado: (2021)

Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making
por: Taylor, Peter C, et al.
Publicado: (2020)

Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
por: Judge, Andy, et al.
Publicado: (2017)

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
por: Nguyen, Thao H. P., et al.
Publicado: (2022)

Using Shared Decision-Making Tools and Patient-Clinician Conversations About Costs
por: Espinoza Suarez, Nataly R., et al.
Publicado: (2020)

Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs
por: Sokka, Tuulikki, et al.
Publicado: (2008)

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2013)

Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response
por: Mikhaylenko, Dmitry S., et al.
Publicado: (2020)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Kerola, Anne Mirjam, et al.
Publicado: (2021)

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
por: Deyab, Gia, et al.
Publicado: (2021)

Decision Needs and Preferred Strategies for Shared Decision‐Making in Rheumatoid Arthritis: Perspectives of Canadian Urban Indigenous Women
por: Umaefulam, Valerie, et al.
Publicado: (2022)

Perioperative shared decision making – How do we train clinicians?
por: Bougeard, Anne-Marie, et al.
Publicado: (2023)

Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis
por: Ortendahl, Monica
Publicado: (2007)

Using Nudges to Enhance Clinicians’ Implementation of Shared Decision Making With Patient Decision Aids
por: Kostick, Kristin M., et al.
Publicado: (2020)

Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis: A Network Meta-Analysis
por: Guski, Louise S., et al.
Publicado: (2023)

Utilization Patterns of Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients
por: Jin, Xue-Mei, et al.
Publicado: (2014)

Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
por: Xia, Yunfei, et al.
Publicado: (2016)

Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis
por: Bliddal, Sofie, et al.
Publicado: (2017)

Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies
por: Fazeli, Mir Sohail, et al.
Publicado: (2021)

The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
por: Hasegawa, Eriko, et al.
Publicado: (2023)

Decision boxes for clinicians to support evidence-based practice and shared decision making: the user experience
por: Giguere, Anik, et al.
Publicado: (2012)

Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision‐making
por: Ankolekar, Anshu, et al.
Publicado: (2022)

Consideration of Shared Decision Making in Nursing: A Review of Clinicians’ Perceptions and Interventions
por: Clark, Noreen M, et al.
Publicado: (2009)

Teaching clinicians shared decision making and risk communication online: an evaluation study
por: Hoffmann, Tammy C, et al.
Publicado: (2021)

Clinician-created educational video for shared decision-making in the outpatient management of acne
por: Hung, Chih-Tsung, et al.
Publicado: (2022)

Subcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
por: Kivitz, Alan, et al.
Publicado: (2014)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

Use of Disease-modifying Antirheumatic Drugs After Cancer Diagnosis in Rheumatoid Arthritis Patients
por: Joo, Young Bin, et al.
Publicado: (2022)

Genders of patients and clinicians and their effect on shared decision making: a participant-level meta-analysis
por: Wyatt, Kirk D, et al.
Publicado: (2014)

Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study
por: Tanaka, Yoshiya, et al.
Publicado: (2022)

Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients
por: de Bandt, Michel, et al.
Publicado: (2009)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen, Kate E, et al.
Publicado: (2021)

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment
por: van Heuckelum, Milou, et al.
Publicado: (2019)

Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia
por: Fletcher, Ashley, et al.
Publicado: (2022)

The effect of disease-modifying antirheumatic drugs on sleep and quality of life in older patients with rheumatoid arthritis
por: Azizli, Ali, et al.
Publicado: (2023)

Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2023)

Evaluation of a shared decision-making intervention for pediatric patients with asthma in the emergency department
por: Reeves, Kelly, et al.
Publicado: (2020)

Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Costello, Ruth E, et al.
Publicado: (2020)

Association of Serum Folate Levels With Cardiovascular Mortality Among Adults With Rheumatoid Arthritis
por: Sonawane, Kalyani, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a7c0tc9bk061f3chp1tvmh2htc